Quinapril Hydrochloride Tablet Shortage: Latest FDA Availability and Manufacturer Updates
Areazine synthesizes this FDA drug-shortage notice directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
The FDA reports an ongoing shortage of Quinapril Hydrochloride tablets, a cardiovascular medication, though some supply remains available through specific manufacturers.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "low" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, Quinapril-Hydrochloride.
What's in Shortage
Quinapril Hydrochloride (Brand Name: QUINAPRIL) in tablet form is currently listed on the FDA drug shortage database. This medication is categorized under cardiovascular treatments. The shortage was first posted on January 19, 2023, and the status was last updated on February 2, 2026.
Which Manufacturers Are Affected
The following manufacturer is currently reporting availability for Quinapril Hydrochloride tablets:
Chartwell Molecular Holdings LLC
- Status: Available
- Presentations:
- 5 mg (NDC 62135-484-60)
- 10 mg (NDC 62135-485-90)
- 20 mg (NDC 62135-486-90)
- 40 mg (NDC 62135-487-90)
- Contact Info: 845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com
Why There's a Shortage
The FDA source data does not provide a specific reason for the current shortage status of Quinapril Hydrochloride.
What Patients Should Do
If you are currently prescribed Quinapril Hydrochloride, consider the following steps:
- Consult your pharmacist: Check if your specific dosage is in stock or if they can source it from the available manufacturer.
- Contact your healthcare provider: Discuss your treatment plan and ask about potential alternatives if you encounter difficulty filling your prescription.
- Contact the manufacturer: You may reach out to Chartwell Molecular Holdings LLC directly using the contact information provided above for updates on supply.
Disclaimer: Patients should always consult their healthcare provider or a qualified medical professional before making any changes to their medication or treatment plan.
Source
Information provided by the FDA Drug Shortage Database.
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Frequently Asked Questions
Common questions about this FDA drug-shortage notice.